Advisory committee meetings
This article was originally published in The Tan Sheet
FDA Advisory Committee for Pharmaceutical Science will meet Oct. 21-22 to discuss manufacturing issues, "receive updates on risk-based chemistry manufacturing control review and blend uniformity" and provide direction for the Process Analytical Technologies Subcommittee, which will meet Oct. 23. PAT subcommittee will discuss computer systems validation, part 11 issues pertinent to PAT, rapid microbiology testing. For more information on either meeting, contact CDER's Kathleen Reedy at (301) 827-7001...
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.